LRP5 and non-small cell lung carcinoma: LRP5 is associated with activation of the Wnt signaling pathway, and in NSCLC, LRP5 polymorphisms play a role in NSCLC susceptibility (Williams and Insogna, 2009; Wang et al., 2016).